About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Risk Stratification in End Stage Renal Disease (ESRD) - ISAR Study

Risk Stratification in End Stage Renal Disease (ESRD) - ISAR Study

NCT01152892·17 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Technical University of Munich

With

Else Kröner Fresenius Foundation
AIT Austrian Institute of Technology GmbH
Ludwig-Maximilians - University of Munich
FH Aachen, University of applied sciences

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

1. Age 18 or older
2. End-stage renal disease (ESRD) and receiving maintenance hemodialysis

You may not be if

1. Any clinically significant infection.
2. pregnancy
3. history of malignant disease with a prognostic life expectancy less than 24 months
4. missing of written and informed consent

The record

StatusUnknown

PhaseNo phase

Taking part500

StartedApr 2010

UpdatedJan 26, 2016

Conditions

End Stage Renal Disease Chronic Kidney Disease Cardiovascular Event Sudden Cardiac Death

Where17

KFH Dialysis Center
Altötting, Bavaria, Germany
KFH Dialysis Center Dillingen
Dillingen an der Donau, Bavaria, Germany
Praxen Dr. Braun Dingolfing
Dingolfing, Bavaria, Germany